Inventor · disambiguated record
Matthew P. Morrow
Also filed as: MORROW MATTHEW · MORROW MATTHEW P
23 granted patents·11 pending applications·36 citations·filing 2009–2025
93Inventor score
Top patents by PatentIndex Score
34 records- 0192US8298820B2Influenza nucleic acid molecules and vaccines made therefromWEINER DAVID B·Filed 2010·Granted Oct 30, 2012·7 cites·12 claims
- 0291US9750795B2Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infectionsUNIV PENNSYLVANIA·Filed 2012·Granted Sep 5, 2017·8 cites·18 claims
- 0389US9981036B2Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the sameUNIV PENNSYLVANIA·Filed 2016·Granted May 29, 2018·6 cites·15 claims
- 0489US9272024B2Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the sameUNIV PENNSYLVANIA·Filed 2012·Granted Mar 1, 2016·9 cites·21 claims
- 0589US2024307527A1Vaccines and immunotherapeutics using il-28 and compositions and methods of using the sameUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0680US10071154B2Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the sameWEINER DAVID B·Filed 2009·Granted Sep 11, 2018·2 cites·16 claims
- 0778US11998598B2Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the sameUNIV PENNSYLVANIA·Filed 2021·Granted Jun 4, 2024·0 cites·16 claims
- 0878US2025255957A1Vaccines having an antigen and interleukin-21 as an adjuvantUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 0977US9192660B2Influenza nucleic acid molecules and vaccines made therefromUNIV PENNSYLVANIA·Filed 2012·Granted Nov 24, 2015·1 cites·19 claims
- 1075US12280108B2Vaccines having an antigen and interleukin-21 as an adjuvantUNIV PENNSYLVANIA·Filed 2021·Granted Apr 22, 2025·0 cites·19 claims
- 1175US2022193230A1Compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the sameUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1274US11027009B2Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the sameUNIV PENNSYLVANIA·Filed 2020·Granted Jun 8, 2021·0 cites·16 claims
- 1373US10925961B2Vaccines with CD40 ligand as an adjuvantUNIV PENNSYLVANIA·Filed 2016·Granted Feb 23, 2021·1 cites·18 claims
- 1471US11241496B2Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the sameUNIV PENNSYLVANIA·Filed 2018·Granted Feb 8, 2022·0 cites·18 claims
- 1571US10980870B2Proteins comprising MRSA Pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infectionsUNIV PENNSYLVANIA·Filed 2018·Granted Apr 20, 2021·0 cites·20 claims
- 1670US10022434B2Influenza nucleic acid molecules and vaccines made therefromWEINER DAVID B·Filed 2014·Granted Jul 17, 2018·1 cites·15 claims
- 1769US10646563B2Vaccines and immunotherapeutics using IL-28 and compositions and methods of usingUNIV PENNSYLVANIA·Filed 2018·Granted May 12, 2020·0 cites·10 claims
- 1869US10363302B2Influenza nucleic acid molecules and vaccines therefromUNIV PENNSYLVANIA·Filed 2018·Granted Jul 30, 2019·0 cites·21 claims
- 1966US9669091B2Vaccines having an antigen and interleukin-23 as an adjuvantWEINER DAVID B·Filed 2014·Granted Jun 6, 2017·1 cites·22 claims
- 2065US2021196818A1Vaccines with interleukin-33 as an adjuvantUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 2165US2024293528A1Methods of treatment of high-grade squamous intraepithelial lesion (hsil)INOVIO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2264US12350318B2Combination therapy to treat brain cancerINOVIO PHARMACEUTICALS INC·Filed 2022·Granted Jul 8, 2025·0 cites·23 claims
- 2364US11007265B2Vaccines having an antigen and interleukin-21 as an adjuvantUNIV PENNSYLVANIA·Filed 2018·Granted May 18, 2021·0 cites·16 claims
- 2463US9884106B2Influenza nucleic acid molecules and vaccines made therefromUNIV PENNSYLVANIA·Filed 2015·Granted Feb 6, 2018·0 cites·23 claims
- 2562US10166288B2Vaccines having an antigen and interleukin-21 as an adjuvantUNIV PENNSYLVANIA·Filed 2015·Granted Jan 1, 2019·0 cites·17 claims
- 2662US2025352620A1Combination therapy to treat brain cancerINOVIO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2761US10130705B2Vaccines with interleukin-33 as an adjuvantUNIV PENNSYLVANIA·Filed 2014·Granted Nov 20, 2018·0 cites·22 claims
- 2859US10933130B2Vaccines with interleukin-33 as an adjuvantUNIV PENNSYLVANIA·Filed 2018·Granted Mar 2, 2021·0 cites·26 claims
- 2959US2024229152A9Methods of Treatment of High-Grade Squamous Intraepithelial Lesion (HSIL)INOVIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3058US10064931B2Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infectionsUNIV PENNSYLVANIA·Filed 2017·Granted Sep 4, 2018·0 cites·18 claims
- 3156US2023338502A1Methods Of Treatment Of High Grade Squamous Intraepithelial Lesion (HSIL)INOVIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3256US2018344842A1Influenza nucleic acid molecules and vaccines made therefromUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 3343US2011184160A1Nucleic acid molecule encoding consensus influenza a hemagglutinin h1WEINER DAVID B·Filed 2010·Application pending·0 cites
- 3436US2020282042A1Clinical and immunologic biomarkers for regression of high grade cervical dysplasia and clearance of hpv16 and hpv18 infection after immunotherapyINOVIO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew P. Morrow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →